Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. (Record no. 28839727)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02561 a2200709 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517235953.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201906s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-5488 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1470-2045(18)30497-2 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Dummer, Reinhard |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190617 |
| 245 00 - TITLE STATEMENT | |
| Title | Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Oncology |
| Date of publication, distribution, etc. | 10 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1315-1327 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzimidazoles |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers, Tumor |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carbamates |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genetic Predisposition to Disease |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Melanoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Progression-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Skin Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonamides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Time Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vemurafenib |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ascierto, Paolo A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gogas, Helen J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Arance, Ana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mandala, Mario |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liszkay, Gabriella |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Garbe, Claus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schadendorf, Dirk |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Krajsova, Ivana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gutzmer, Ralf |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chiarion Sileni, Vanna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dutriaux, Caroline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Groot, Jan Willem B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yamazaki, Naoya |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Loquai, Carmen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moutouh-de Parseval, Laure A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pickard, Michael D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sandor, Victor |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Robert, Caroline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Flaherty, Keith T |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Oncology |
| Related parts | vol. 19 |
| -- | no. 10 |
| -- | p. 1315-1327 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1470-2045(18)30497-2">https://doi.org/10.1016/S1470-2045(18)30497-2</a> |
| Public note | Available from publisher's website |
No items available.